Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery - Wikidata - awgldk - TriplyDB

Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery

Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery

http://www.wikidata.org/entity/Q33626905

about

Targeted Lung Delivery of Nasally Administered Aerosols Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.Particle transport in the human respiratory tract: formulation of a nodal inverse distance weighted Eulerian-Lagrangian transport and implementation of the Wind-Kessel algorithm for an oral delivery.Recommendations for Simulating Microparticle Deposition at Conditions Similar to the Upper Airways with Two-Equation Turbulence Models

P2860

Q28387568-07E98703-6D9B-45FC-BE0F-2E46C1A5578F Q30945192-F6DFE2FE-1679-41CF-BB32-870972398C92 Q34861310-A0DE77C8-7D6A-458F-9532-7AAED21697E4 Q36024362-41342F88-F631-4F6F-B747-2B8B2D904003 Q36559720-05ABA78F-F6F6-4F21-8F43-9B572687AA52 Q39848034-7D3E0BCC-CFBC-4055-84DD-C560B7575287 Q45050545-75C2858F-0CD9-4EBE-8703-3465DF239DB2 Q50861783-46E448A0-2246-4AE6-B9C3-E2B734F7EAD6 Q57825732-609DFED9-0B95-48EA-B7AC-A1FB45F03013

P2860

Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery

http://www.wikidata.org/entity/Q33626905

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Development of characteristic ...... harmaceutical aerosol delivery

@ast

Development of characteristic ...... harmaceutical aerosol delivery

@en

type

label

Development of characteristic ...... harmaceutical aerosol delivery

@ast

Development of characteristic ...... harmaceutical aerosol delivery

@en

prefLabel

Development of characteristic ...... harmaceutical aerosol delivery

@ast

Development of characteristic ...... harmaceutical aerosol delivery

@en

P1433

Q33626905-966F426A-98F0-4D0C-A26A-752593413021

P1476

Q33626905-320C1916-A43B-4EAA-B3A8-07E229274EDA

P2093

Q33626905-1CA18215-A533-49C7-ABB2-FDC35EBE757E

Q33626905-2BC230C9-84C3-43BD-A008-DBBF540A3D29

Q33626905-83656690-C1B7-41E4-BA77-50717EAD0E11

P2860

Q33626905-07E9F962-997E-4F1D-9A1B-07E97CC0C687

Q33626905-12154B85-CAEA-4F8A-9559-897EB4D93EAA

Q33626905-12B42545-98D7-4490-9140-A36B31C85921

Q33626905-15531D4C-A6BB-49F3-B1C8-435E5EDBBBD9

Q33626905-165E85A0-9664-40A7-94E9-060E1A20A557

Q33626905-17F6AB5E-6E42-4520-AC04-2BFF7364A730

Q33626905-1BFBDCA9-FC2E-4B8D-830F-FDA1E0CC9B06

Q33626905-1C3A2933-99C4-42CD-902D-8FB754F87795

Q33626905-1E57F4A9-0401-439E-81DA-F3695990DDEF

Q33626905-1F208DDB-9DBF-4B66-8EB1-5D250FEA0B88

P304

Q33626905-5D2FA8BA-0E67-42ED-9E6E-C76FC968A252

P31

Q33626905-544DF5F6-7F35-461E-ADAC-0DC6443758AC

P356

Q33626905-7D2ABEBE-0770-414A-90AB-19BFD71DE1E7

P433

Q33626905-5C57845C-09C5-4618-A4D7-2749FB1A402C

P478

Q33626905-F1A73949-B9C7-42E2-AD1A-A1323875E97C

P577

Q33626905-007A7CFF-0BFC-46B1-A4C6-C6A0E60363B3

P5875

Q33626905-EE4BDDFE-9E24-43D4-AB55-B4D235EB3FEF

P698

Q33626905-B7B24AFA-240D-44FB-8B51-221589AC2B6F

P932

Q33626905-BC847B0F-ED4B-48AC-9EEC-904497BADE3A

P356

P1433

Journal of Biomechanical Engineering

P1476

Development of characteristic ...... harmaceutical aerosol delivery

@en

P2093

Geng Tian

http://www.w3.org/2001/XMLSchema#string

P Worth Longest

http://www.w3.org/2001/XMLSchema#string

Ross L Walenga

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways

Effects of mesh style and grid convergence on particle deposition in bifurcating airway models with comparisons to experimental data.

Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.

Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.

3D airway reconstruction using visible human data set and human casts with comparison to morphometric data.

Evolution of dry powder inhaler design, formulation, and performance.

Comparison of deposition in the USP and physical mouth-throat models with solid and liquid particles

Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: comparison of CFD predictions with experimental results

Characteristics of the turbulent laryngeal jet and its effect on airflow in the human intra-thoracic airways.

On intra- and intersubject variabilities of airflow in the human lungs

P304

91010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1115/1.4024630

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236977271

http://www.w3.org/2001/XMLSchema#string

P698

23722698

http://www.w3.org/2001/XMLSchema#string

P932

5413171

http://www.w3.org/2001/XMLSchema#string